BMPR2 and pulmonary arterial hypertension: Bone morphogenic protein type II receptor (BMPR2) is the most vastly studied PAH-inducing factor and has been described as a major influence in the development of PAH [10]; more than 26% of IPAH patients have a mutation in the BMPR2 gene [11].